GLAND PHARMA
Back to Cashflow Statement
|
GLAND PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-1,560 Cr | ₹1,587 Cr | ₹-177 Cr | ₹319 Cr | ₹-72 Cr |
What is the latest Net Cash Inflow / Outflow ratio of GLAND PHARMA ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹-1,560 Cr |
Mar2023 | ₹1,587 Cr |
Mar2022 | ₹-177 Cr |
Mar2021 | ₹319 Cr |
Mar2020 | ₹-72 Cr |
How is Net Cash Inflow / Outflow of GLAND PHARMA Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹-1,560 Cr | Negative | |
Mar2023 | ₹1,587 Cr | Positive | |
Mar2022 | ₹-177 Cr | Negative | |
Mar2021 | ₹319 Cr | Positive | |
Mar2020 | ₹-72 Cr | - |
Compare Net Cash Inflow / Outflow of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹31,124.1 Cr | 0.1% | 11.8% | -6.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,580.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,069.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
CIPLA | ₹119,919.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,310.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,402.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | 0.1% |
11.8% |
-6.3% |
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses